WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes.
The agency cleared the company’s drug, Tanzeum, to help patients control their blood sugar levels, in combination with diet and exercise.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.